Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-323214
Filing Date
2021-11-08
Accepted
2021-11-08 17:22:05
Documents
6
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d164684ddef14a.htm DEF 14A 686872
2 GRAPHIC g164684g23n30.jpg GRAPHIC 120802
3 GRAPHIC g164684g32z91.jpg GRAPHIC 48030
4 GRAPHIC g164684g72x65.jpg GRAPHIC 127324
5 GRAPHIC g164684g84j39.jpg GRAPHIC 58110
6 GRAPHIC g164684g86v37.jpg GRAPHIC 22210
  Complete submission text file 0001193125-21-323214.txt   1200716
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38959 | Film No.: 211388967
SIC: 2834 Pharmaceutical Preparations